Louis Cannon, MD, FACC, FACP

Drug-Eluting Stent Solutions: Evaluating Endpoints in Drug-Eluting Stent (DES) Trials

06/19/2008

When evaluating clinical trials of DES, which endpoints do you think are most important? Target lesion revascularization (TLR) is the first endpoint I look at when evaluating a clinical trial. There are two types of TLR: clinicall driven and...

When evaluating clinical trials...

06/19/2008

Cath Lab Digest

Drug-Eluting Stent Solutions: Vessel Size and DES: Treatment Strategies

06/19/2008

Louis Cannon , MD, FACC, FACP;

What were some of the issues in treating certain vessel sizes in the past? Five years ago, any vessel less than 3.0 mm in diameter was considered a small vessel. Now, small vessels are those that are less than 2.5 to 2.75 mm. Treating...

What were some of the issues in...

06/19/2008

Cath Lab Digest

Feature

Drug-Eluting Stent Solutions: Evaluating Endpoints in Drug-Eluting Stent (DES) Trials

06/19/2008

Louis Cannon , MD, FACC, FACP;

When evaluating clinical trials...

06/19/2008

Cath Lab Digest

Feature

Drug-Eluting Stent Solutions: Vessel Size and DES: Treatment Strategies

06/19/2008

Louis Cannon , MD, FACC, FACP;

What were some of the issues in...

06/19/2008

Cath Lab Digest

Original Contribution

Clinical Experience with a Circumferential Clip-Based Vascular Closure Device in Diagnostic Catheterization

08/01/2008

Carol Anne Yarbrough , RN;

Michael Zapien ;

Charles A. Simonton III, MD;

Louis Cannon , MD, FACC, FACP;

Daniel T. Lee , MD;

Michael R. Mooney , MD;

James B. Hermiller , MD, FACC, FSCAI;

Tony M. Chou , MD;

Tomoaki Hinohara , MD;

Harold Carlson , MD;

Charles O'Shaughnessy , MD;

Richard Fortuna , MD, PhD;

Approximately 7 million angiograms and interventional procedures are performed worldwide each year, and the incidence of these procedures continues to rise, particularly in developing countries. The vast majority of these procedures are...

Approximately 7 million...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Impact of Contrast Dose Reduction on Incidence of Acute Kidney Injury (AKI) Among Patients Undergoing PCI: A Modeling Study

01/15/2016

Roxana Mehran , MD;

Hitinder S. Gurm , MBBS, MD, FSCAI;

Cindy L. Grines , MD, FACC, FSCAI;

Thomas A. LaLonde , MD;

Milan Seth , BS, MS;

Carlo Briguori , MD, PhD;